Eikon Therapeutics

We’re so proud of #TeamEikon for how they support and give back to our communities! Eikon’s Veterans Employee Resource Group (ERG) includes 11 veterans, military spouses, and military supporters. This recent partnership with Operation Homefront is the first of many events planned in the coming months where the group will be volunteering and showing support for our local military community.

We’re looking forward to the Morgan Stanley 22nd?Annual Global Healthcare Conference on Sept. 4th in New York City. Eikon Therapeutics’ CEO?Roger M. Perlmutter?and CFO?Alfred (Freddie) Bowie?will present a business update on the company’s progress including recent advancements in the company’s pipeline and clinical development programs, as well as updates related to our Eikon Systems business. To access the archived recording after the event, visit the link in comments.?

"I’m excited about the prospect that new technological advances have afforded us to further accelerate innovative therapeutic development.” Ten years after playing an instrumental role in bringing Keytruda —one of the most impactful cancer therapies in history— to market, Roy Baynes, MD, PhD, now serves as?Eikon?Therapeutics' Chief Medical Officer. At?Eikon, Roy is building one of the industry's most sophisticated clinical organizations and a therapeutic pipeline with the potential to deliver important new medicines to address serious illnesses?that reflect areas of unmet?medical need. In a recent podcast interview, Roy shared insights from his accomplished career and discussed what excites him most about the future of medicine, particularly the potential of new technologies and artificial intelligence. Catch the full interview and explore current opportunities to join Roy's growing clinical team at?Eikon?(links in comments). #TeamEikon #Biotech

We're looking forward to next week's Goldman Sachs Global Healthcare Conference, where our CEO, Roger M. Perlmutter, and CFO, Alfred (Freddie) Bowie, will be providing important business updates and highlighting the exciting progress of our lead clinical programs, along with key data presented at the recent #AACR24 and #ASCO24 meetings. To learn more and access an archived recording of the presentation, please visit: www.EikonTx.com/news. #TeamEikon #Biotech

If you’re keen to learn more about Eikon's progress over recent months, check us out at ASCO (and link below), follow on LinkedIn or leave a comment. #eikontx #science #engineering #therapeutics

Excited to connect with colleagues, collaborators, and the clinical oncology community at #ASCO24! #TeamEikon will be sharing updates from our EIK1001 and EIK1003 programs and hosting meetings at Exhibit Hall Booth 32116. Swing by and say hi! Discover more about our abstracts: https://lnkd.in/g2DP-vpu

#AI is top of mind across biopharma R&D organizations and Eikon CEO Roger Perlmutter will be on-site in New York City speaking to this important industry topic next week at the US #Pharma & #Biotech Summit hosted by Endpoints News and the Financial Times. With Andrew Dunn at the helm and a panel that includes Regeneron, Iambic Therapeutics, and Benchling, it's sure to be an engaging conversation! #FTPharma #TeamEikon

This Earth Day, #TeamEikon partnered with Save The Bay for a day of community volunteering in our own backyard at Eden Landing Ecological Reserve. Together, we cleared 480 pounds (!) of invasive weeds. It was not only productive but also incredibly enjoyable contributing positively to our beautiful Bay Area environment and collaborating with colleagues across different departments. A BIG thank you to everyone who brought their energy and community spirit to the day! It truly embodied the spirit of Eikon. #EarthDay #EarthMonth #CommunityService #LoveWhereYouWork #EiKare

It was a privilege to connect with the cancer research community last week at #AACR24 in San Diego. #TeamEikon enjoyed sharing data from our TLR7/8 agonist program (EIK1001) and interacting with the best minds in #cancerresearch from institutions around the world. Carolyn Cho did an incredible job presenting our poster, which you can now find online at: https://lnkd.in/g2chZeyQ Next stop, #ASCO24!

#TeamEikon is pleased to be part of this year's Biophysical Society meeting in Philadelphia and honored to be featured in a BPS TV video showcasing how our single-molecule tracking (SMT) platform is powering our work to identify new targets and bring novel therapies to patients. If you are at #bps2024 and want to connect, reach out to Eikon CSO Daniel J Anderson. https://lnkd.in/gsUkXf_2